Every year in our country, we lose about two thousand women to breast cancer, and almost five hundred to cervical cancer – even though we know that early diagnosis and modern therapies greatly improve the chances of recovery. Roche Hungary has therefore announced a broad collaboration in the healthcare sector and among other large companies in order to increase the number of screening tests in health areas affecting women, which had decreased due to the coronavirus.